In this photo illustration, the Sage Therapeutics logo of a biopharmaceutical company seen on a smartphone and on a pc screen. Pavlo Gonchar | SOPA Images | Lightrocket | Getty …
WASHINGTON — Federal health officials have approved the first pill specifically intended to treat severe depression after childbirth, a condition that affects thousands of new mothers in the U.S. each …
The Food and Drug Administration (FDA) has given approval for the first-ever pill designed specifically to treat postpartum depression. This pill, called zuranolone and marketed as Zurzuvae, is taken once …
About one in eight women in the United States experiences postpartum depression after giving birth. Soon, there may finally be a convenient, fast-acting medication to treat it—if the Food and …